Pincus Llc Warburg Net Worth

The estimated Net Worth of Pincus Llc Warburg is at least $733 Million dollars as of 13 April 2021. Pincus Warburg owns over 3,890,723 units of Outset Medical stock worth over $415,851 and over the last 18 years Pincus sold OM stock worth over $732,799,781.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Pincus Warburg OM stock SEC Form 4 insiders trading

Pincus has made over 6 trades of the Outset Medical stock since 2017, according to the Form 4 filled with the SEC. Most recently Pincus sold 3,890,723 units of OM stock worth $197,765,450 on 13 April 2021.

The largest trade Pincus's ever made was selling 4,109,128 units of Outset Medical stock on 22 August 2017 worth over $135,806,680. On average, Pincus trades about 885,994 units every 79 days since 2007. As of 13 April 2021 Pincus still owns at least 815,394 units of Outset Medical stock.

You can see the complete history of Pincus Warburg stock trades at the bottom of the page.

What's Pincus Warburg's mailing address?

Pincus's mailing address filed with the SEC is 450 Lexington Ave, New York, NY 10017, USA.

Insiders trading at Outset Medical

Over the last 4 years, insiders at Outset Medical have traded over $829,589,795 worth of Outset Medical stock and bought 42,000 units worth $1,172,030 . The most active insiders traders include Pincus Llc Warburg, Pincus X, L.P.Warburg Pincu..., and Pincus X, L.P.Wp X Finance,.... On average, Outset Medical executives and independent directors trade stock every 7 days with the average trade being worth of $44,055. The most recent stock trade was executed by Leslie Trigg on 15 August 2024, trading 5,308 units of OM stock currently worth $4,459.

What does Outset Medical do?

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Complete history of Pincus Warburg stock trades at Arch Capital Ltd, Arch Capital Ltd, Laredo Petroleum, Arch Capital Ltd, and Outset Medical

Outset Medical executives and stock owners

Outset Medical executives and other stock owners filed with the SEC include:

• Leslie L. Trigg,
  Pres, CEO & Director
• Martin Vazquez,
  Chief Operating Officer
• Nabeel Ahmed,
  CFO, Principal Financial Officer & Principal Accounting Officer
• Jean-Olivier Racine,
  Chief Technology Officer
• Steven S. Williamson,
  Chief Commercial Officer
• Jeffrey Hussey,
  President, Chief Operating Officer, Director
• Robin Adair,
  Vice President - Exploration
• Paul Dumas,
  Executive Vice President - Finance, Director
• Anthony Glavac,
  Chief Financial Officer
• Robert Wares,
  Executive Chairman of the Board, Chief Executive Officer
• Cathy Singer,
  Independent Director
• Donald Siemens,
  Independent Director
• Amy Satov,
  Independent Director
• Luc Lessard,
  Independent Director
• John Burzynski,
  Independent Director
• Lili Mance,
  Corporate Secretary
• Killian Charles,
  Vice President - Corporate Development
• James S. Mazzola,
  Head of Investor Relations
• Tonya Saffer,
  Head of Gov. Affairs & Market Access
• Dr. Michael Aragon M.D.,
  Chief Medical Officer
• Stacey L. Porter,
  Chief People Officer
• Nicole Shannon,
  Director of Marketing Communications
• John L. Brottem,
  Gen. Counsel & Sec.
• Brent D. Lang,
  Director
• Pincus X, L.P.Warburg Pincu...,
  
• Pincus Llc Warburg,
  
• Martin Vazquez,
  Chief Operating Officer
• Catherine M. Szyman,
  Director
• Pincus X, L.P.Warburg Pincu...,
  
• Pincus X, L.P.Warburg Pincu...,
  
• Pincus X, L.P.Wp X Finance,...,
  
• Rebecca Chambers,
  Chief Financial Officer
• Leslie Trigg,
  Chair and CEO
• D Keith Grossman,
  Director
• Jean Olivier Racine,
  Chief Technology Officer
• Karen Drexler,
  Director
• Patrick T Hackett,
  Director
• James F. Hinrichs,
  Director
• Stacey L. Porter,
  Chief People Officer
• Dale E Jones,
  Director
• Nabeel Ahmed,
  Chief Financial Officer
• Steven S. Williamson,
  Chief Commercial Officer
• John L. Brottem,
  General Counsel
• Marc Nash,
  SVP Operations and R&D